Clinical Trial Update: Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 2/Phase 3 clinical trial evaluating nalmefene hydrochloride for gambling disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gambling Disorder

Drugs mentioned

• Nalmefene HCl (nalmefene)

Snippet

Sponsor: Somaxon Pharmaceuticals | Conditions: Pathological Gambling | Phase 2, Phase 3 | Status: COMPLETED